Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 78

Results For "IDA"

1816 News Found

North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh
Policy | March 11, 2024

North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh

The institution will be spread over an area of more than 8 acres


Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh
Biotech | March 07, 2024

Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh

India has reached to nearly 6,000 bio-startups from 50 in the past 10 years


Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme
Policy | March 07, 2024

Venus Remedies awarded its first incentive of Rs.7.50 crore under PLl scheme

The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics


Bayer aims to enhance performance and regain strategic flexibility by 2026
News | March 06, 2024

Bayer aims to enhance performance and regain strategic flexibility by 2026

Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis


BlueRock Therapeutics Phase I clinical trial for Parkinson’s disease continues to show positive trends
Diagnostic Center | March 06, 2024

BlueRock Therapeutics Phase I clinical trial for Parkinson’s disease continues to show positive trends

Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months


Ami Organics granted patent
News | March 04, 2024

Ami Organics granted patent

With this, the total number of Patents granted to company for its innovative processes and technology stands at 9


Suven announces merger of Cohance Lifesciences
News | March 01, 2024

Suven announces merger of Cohance Lifesciences

The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals


New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions with food allergies
Diagnostic Center | February 28, 2024

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions with food allergies

The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies


Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
News | February 24, 2024

Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India

Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully


Aptar Digital Health acquires Healint to broaden neurology portfolio
News | February 23, 2024

Aptar Digital Health acquires Healint to broaden neurology portfolio

The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment